Periostin Promotes Invasiveness and Metastasis of Oral Cancer<i>via</i>Epithelial-mesenchymal Transition
Periostin promotes OSCC progression by enhancing invasiveness and metastasis <i>via</i> EMT. It represents a potential prognostic marker and therapeutic target. These findings highlight the need for further clinical validation of periostin-targeted therapies for management of OSCC.
Authors
- Ji‐Hyun Seo (ORCID: https://orcid.org/0000-0002-0691-3957)
- Chae Dong Yim (ORCID: https://orcid.org/0000-0002-2110-1092)
- Young‐Sool Hah (ORCID: https://orcid.org/0000-0002-8571-2722)
- Jung Je Park (ORCID: https://orcid.org/0000-0001-6325-0398)
- Sang-Wook Park (ORCID: https://orcid.org/0000-0001-6996-5853)
- Seongjun Won (ORCID: https://orcid.org/0000-0003-4163-4053)
- So Young Cheon
- S.H. Lee
Institutions
- Gyeongsang National University (KR)
- Gyeongsang National University Hospital (KR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/anticanres.17674
- Citations
- 2
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 2.78